Off-label use of hormones as an antiaging strategy: a review

References

• BinstockRHAnti-aging medicine and research: a realm of conflict and profound societal implicationsJ Gerontol A Biol Sci Med Sci200459B523B53315215257
   PubMed Web of Science ®Google Scholar
• StuckelbergerAAnti-ageing Medicine. Myths and Chances1st edZürich, SwitzerlandHochschulverlag2008
   Google Scholar
• ZouboulisCCMakrantonakiEHormonal therapy of intrinsic agingRejuvenation Res20121530231222533363
   PubMed Web of Science ®Google Scholar
• SamarasNSamarasDFrangosEForsterAPhilippeJA review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial?Rejuvenation Res201316428529423647054
   PubMed Web of Science ®Google Scholar
• SamarasNSamarasDLangPOA view of geriatrics through hormones. What is the relation between andropause and well-known geriatric syndromes?Maturitas2013743213219
   Web of Science ®Google Scholar
• SitesCKBioidentical hormones for menopausal therapyWomens Health (Lond Engl)2008416317119072518
   PubMedGoogle Scholar
• MontplaisirJLorrainJDenesleRPetitDSleep in menopause: differential effects of two forms of hormone replacement therapyMenopause20018101611201509
   PubMed Web of Science ®Google Scholar
• CiriglianoMBioidentical hormone therapy: a review of the evidenceJ Womens Health (Larchmt)20071660063117627398
   PubMed Web of Science ®Google Scholar
• MacLennanALesterSMooreVOral oestrogen replacement therapy versus placebo for hot flushesCochrane Database Syst Rev20011CD00297811279791
   PubMedGoogle Scholar
• CauleyJARobbinsJChenZEffects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trialJAMA20032901729173814519707
   PubMed Web of Science ®Google Scholar
• RymerJMorrisEPExtracts from “Clinical Evidence”: menopausal symptomsBMJ20003211516151911118182
   PubMed Web of Science ®Google Scholar
• RossouwJEAndersonGLPrenticeRLRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trialJAMA200228832133312117397
   PubMed Web of Science ®Google Scholar
• HershALStefanickMLStaffordRSNational use of postmenopausal hormone therapy: annual trends and response to recent evidenceJAMA2004291475314709575
   PubMed Web of Science ®Google Scholar
• Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause SocietyMenopause20071416818217259911
   PubMed Web of Science ®Google Scholar
• EttingerBEnsrudKEWallaceREffects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trialObstet Gynecol200410444345115339752
   PubMed Web of Science ®Google Scholar
• KaufertPBoggsPPEttingerBWoodsNFUtianWHWomen and menopause: beliefs, attitudes, and behaviors. The North American Menopause Society. 1997 Menopause SurveyMenopause199851972029872483
   PubMed Web of Science ®Google Scholar
• FilesJAKoMGPruthiSBioidentical hormone therapyMayo Clin Proc20118667368021531972
   PubMed Web of Science ®Google Scholar
• Coelingh BenninkHJAre all estrogens the same?Maturitas20044726927515063479
   PubMed Web of Science ®Google Scholar
• L’HermiteMSimonciniTFullerSGenazzaniARCould transdermal estradiol + progesterone be a safer postmenopausal HRT? A reviewMaturitas20086018520118775609
   PubMed Web of Science ®Google Scholar
• CanonicoMOgerEPlu-BureauGHormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER studyCirculation200711584084517309934
   PubMed Web of Science ®Google Scholar
• SchunkertHDanserAHHenseHWDerkxFHKurzingerSRieggerGAEffects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal womenCirculation19979539458994414
   PubMed Web of Science ®Google Scholar
• BlumelJECastelo-BrancoCLealTEffects of transdermal estrogens on endothelial function in postmenopausal women with coronary diseaseClimacteric20036384412725663
   PubMed Web of Science ®Google Scholar
• Le GalGGourletVHogrelPPlu-BureauGTouboulPJScarabinPYHormone replacement therapy use is associated with a lower occurrence of carotid atherosclerotic plaques but not with intima-media thickness progression among postmenopausal women. The vascular aging (EVA) studyAtherosclerosis200316616317012482563
   PubMed Web of Science ®Google Scholar
• OpatrnyLDell’AnielloSAssoulineSSuissaSHormone replacement therapy use and variations in the risk of breast cancerBJOG2008115169175 discussion 7518081598
   PubMed Web of Science ®Google Scholar
• LippertCSeegerHMueckAOThe effect of endogenous estradiol metabolites on the proliferation of human breast cancer cellsLife Sci20037287788312493568
   PubMed Web of Science ®Google Scholar
• MueckAOSeegerHBreast cancer: are estrogen metabolites carcinogenic?Climacteric200710Suppl. 2626517882675
   PubMed Web of Science ®Google Scholar
• LyytinenHPukkalaEYlikorkalaOBreast cancer risk in postmenopausal women using estrogen-only therapyObstet Gynecol20061081354136017138766
   PubMed Web of Science ®Google Scholar
• FournierABerrinoFClavel-ChapelonFUnequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort studyBreast Cancer Res Treat200810710311117333341
   PubMed Web of Science ®Google Scholar
• KuiperGGCarlssonBGrandienKComparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and betaEndocrinology19971388638709048584
   PubMed Web of Science ®Google Scholar
• WeiderpassEBaronJAAdamiHOLow-potency oestrogen and risk of endometrial cancer: a case-control studyLancet19993531824182810359406
   PubMed Web of Science ®Google Scholar
• RosenbergLUMagnussonCLindstromEWedrenSHallPDickmanPWMenopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control studyBreast Cancer Res20068R1116507159
   PubMed Web of Science ®Google Scholar
• IosifCSEffects of protracted administration of estriol on the lower genito urinary tract in postmenopausal womenArch Gynecol Obstet19922511151201605675
   PubMed Web of Science ®Google Scholar
• TakahashiKManabeAOkadaMKuriokaHKanasakiHMiyazakiKEfficacy and safety of oral estriol for managing postmenopausal symptomsMaturitas20003416917710714912
   PubMed Web of Science ®Google Scholar
• MinaguchiHUemuraTShirasuKEffect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open studyJ Obstet Gynaecol Res1996222592658840712
   PubMedGoogle Scholar
• RazRStammWEA controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infectionsN Engl J Med19933297537568350884
   PubMed Web of Science ®Google Scholar
• YangTSTsanSHChangSPNgHTEfficacy and safety of estriol replacement therapy for climacteric womenZhonghua Yi Xue Za Zhi (Taipei)1995553863917641124
   PubMedGoogle Scholar
• MoskowitzDA comprehensive review of the safety and efficacy of bioidentical hormones for the management of menopause and related health risksAltern Med Rev20061120822317217322
   PubMed Web of Science ®Google Scholar
• Sitruk-WareRPharmacological profile of progestinsMaturitas20044727728315063480
   PubMed Web of Science ®Google Scholar
• Sitruk-WareRProgestogens in hormonal replacement therapy: new molecules, risks, and benefitsMenopause2002961511791081
   PubMed Web of Science ®Google Scholar
• SchmidtIUWakleyGKTurnerRTEffects of estrogen and progesterone on tibia histomorphometry in growing ratsCalcif Tissue Int200067475210908413
   PubMed Web of Science ®Google Scholar
• The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) TrialJAMA19952731992087807658
   PubMed Web of Science ®Google Scholar
• FournierABerrinoFRiboliEAvenelVClavel-ChapelonFBreast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohortInt J Cancer200511444845415551359
   PubMed Web of Science ®Google Scholar
• WrenBGChampionSMWillettsKMangaRZEdenJATransdermal progesterone and its effect on vasomotor symptoms, blood lipid levels, bone metabolic markers, moods, and quality of life for postmenopausal womenMenopause200310131812544672
   PubMed Web of Science ®Google Scholar
• WrenBGMcFarlandKEdwardsLEffect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal womenClimacteric2000315516011910616
   PubMedGoogle Scholar
• PanjariMDavisSRDHEA therapy for women: effect on sexual function and wellbeingHum Reprod Update20071323924817208951
   PubMed Web of Science ®Google Scholar
• GenazzaniADLanzoniCGenazzaniARMight DHEA be considered a beneficial replacement therapy in the elderly?Drugs Aging20072417318517362047
   PubMed Web of Science ®Google Scholar
• HydeZFlickerLAlmeidaOPLow free testosterone predicts frailty in older men: the health in men studyJ Clin Endocrinol Metab2010953165317220410223
   PubMed Web of Science ®Google Scholar
• DunnJFNisulaBCRodbardDTransport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasmaJ Clin Endocrinol Metab19815358687195404
   PubMed Web of Science ®Google Scholar
• PardridgeWMSerum bioavailability of sex steroid hormonesClin Endocrinol Metab1986152592783521955
   PubMedGoogle Scholar
• LeifkeEGorenoiVWichersCVon Zur MuhlenAVon BurenEBrabantGAge-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohortClin Endocrinol (Oxf)20005368969511155090
   PubMed Web of Science ®Google Scholar
• MorleyJEKimMJHarenMTFrailty and hormonesRev Endocr Metab Disord2005610110815843881
   PubMed Web of Science ®Google Scholar
• WuFCTajarAPyeSRHypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging StudyJ Clin Endocrinol Metab2008932737274518270261
   PubMed Web of Science ®Google Scholar
• LapauwBGoemaereSZmierczakHThe decline of serum testosterone levels in community-dwelling men over 70 years of age: descriptive data and predictors of longitudinal changesEur J Endocrinol200815945946818593825
   PubMed Web of Science ®Google Scholar
• SattlerFRCastaneda-SceppaCBinderEFTestosterone and growth hormone improve body composition and muscle performance in older menJ Clin Endocrinol Metab2009941991200119293261
   PubMed Web of Science ®Google Scholar
• StorerTWWoodhouseLMaglianoLChanges in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older menJ Am Geriatr Soc2008561991199918795988
   PubMed Web of Science ®Google Scholar
• HydeZNormanPEFlickerLLow free testosterone predicts mortality from cardiovascular disease but not other causes: the Health in Men StudyJ Clin Endocrinol Metab20089717918922013106
   PubMed Web of Science ®Google Scholar
• BainJAndropause. Testosterone replacement therapy for aging menCan Fam Physician200147919711212438
   PubMed Web of Science ®Google Scholar
• Emmelot-VonkMHVerhaarHJNakhai PourHREffect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trialJAMA2008299395218167405
   PubMed Web of Science ®Google Scholar
• ChuLWTamSLeePWBioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older menClin Endocrinol (Oxf)20086858959817973937
   PubMed Web of Science ®Google Scholar
• Srinivas-ShankarURobertsSAConnollyMJEffects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled studyJ Clin Endocrinol Metab20109563965020061435
   PubMed Web of Science ®Google Scholar
• KennyAMKleppingerAAnnisKEffects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels, low bone mass, and physical frailtyJ Am Geriatr Soc2010581134114320722847
   PubMed Web of Science ®Google Scholar
• SnyderPJPeacheyHHannoushPEffect of testosterone treatment on bone mineral density in men over 65 years of ageJ Clin Endocrinol Metab1999841966197210372695
   PubMed Web of Science ®Google Scholar
• CherrierMMAsthanaSPlymateSTestosterone supplementation improves spatial and verbal memory in healthy older menNeurology200157808811445632
   PubMed Web of Science ®Google Scholar
• CherrierMMMatsumotoAMAmoryJKTestosterone improves spatial memory in men with Alzheimer disease and mild cognitive impairmentNeurology2005642063206815985573
   PubMed Web of Science ®Google Scholar
• CherrierMMMatsumotoAMAmoryJKCharacterization of verbal and spatial memory changes from moderate to supraphysiological increases in serum testosterone in healthy older menPsychoneuroendocrinology200732727917145137
   PubMed Web of Science ®Google Scholar
• JanowskyJSChavezBOrwollESex steroids modify working memoryJ Cogn Neurosci20001240741410931767
   PubMed Web of Science ®Google Scholar
• JanowskyJSOviattSKOrwollESTestosterone influences spatial cognition in older menBehav Neurosci19941083253328037876
   PubMed Web of Science ®Google Scholar
• LuPHMastermanDAMulnardREffects of testosterone on cognition and mood in male patients with mild Alzheimer disease and healthy elderly menArch Neurol20066317718516344336
   PubMed Web of Science ®Google Scholar
• TanRSPuSJA pilot study on the effects of testosterone in hypogonadal aging male patients with Alzheimer’s diseaseAging Male20036131712809076
   PubMedGoogle Scholar
• KennyAMBellantonioSGrumanCAAcostaRDPrestwoodKMEffects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levelsJ Gerontol A Biol Sci Med Sci200257M321M32511983727
   PubMed Web of Science ®Google Scholar
• HydeZNormanPEFlickerLElevated LH predicts ischaemic heart disease events in older men: the Health in Men StudyEur J Endocrinol201116456957721285084
   PubMed Web of Science ®Google Scholar
• YeapBBHydeZNormanPEChubbSAGolledgeJAssociations of total testosterone, sex hormone-binding globulin, calculated free testosterone, and luteinizing hormone with prevalence of abdominal aortic aneurysm in older menJ Clin Endocrinol Metab2010951123113020061425
   PubMed Web of Science ®Google Scholar
• RosanoGMSheibanIMassaroRLow testosterone levels are associated with coronary artery disease in male patients with anginaInt J Impot Res20071917618216943795
   PubMed Web of Science ®Google Scholar
• EnglishKMMandourOSteedsRPDiverMJJonesTHChannerKSMen with coronary artery disease have lower levels of androgens than men with normal coronary angiogramsEur Heart J20002189089410806012
   PubMed Web of Science ®Google Scholar
• YeapBBHydeZAlmeidaOPLower testosterone levels predict incident stroke and transient ischemic attack in older menJ Clin Endocrinol Metab2009942353235919351733
   PubMed Web of Science ®Google Scholar
• OhlssonCBarrett-ConnorEBhasinSHigh serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic Fractures in Men) Study in SwedenJ Am Coll Cardiol2011581674168121982312
   PubMed Web of Science ®Google Scholar
• LiuPYDeathAKHandelsmanDJAndrogens and cardiovascular diseaseEndocr Rev20032431334012788802
   PubMed Web of Science ®Google Scholar
• RosanoGMLeonardoFPagnottaPAcute anti-ischemic effect of testosterone in men with coronary artery diseaseCirculation1999991666167010190874
   PubMed Web of Science ®Google Scholar
• EnglishKMSteedsRPJonesTHDiverMJChannerKSLow-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled studyCirculation20001021906191111034937
   PubMed Web of Science ®Google Scholar
• BasariaSCovielloADTravisonTGAdverse events associated with testosterone administrationN Engl J Med201036310912220592293
   PubMed Web of Science ®Google Scholar
• VigenRO’DonnellCIBaronAEAssociation of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levelsJAMA20133101829183624193080
   PubMed Web of Science ®Google Scholar
• WaldMMeachamRBRossLSNiederbergerCSTestosterone replacement therapy for older menJ Androl20062712613216474018
   PubMed Web of Science ®Google Scholar
• BhasinSBasariaSDiagnosis and treatment of hypogonadism in menBest Pract Res Clin Endocrinol Metab20112525127021397197
   PubMed Web of Science ®Google Scholar
• NobleRLThe development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administrationCancer Res19773719291933858144
   PubMed Web of Science ®Google Scholar
• PierorazioPMFerrucciLKettermannALongoDLMetterEJCarterHBSerum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of AgingBJU Int201010582482919751256
   PubMed Web of Science ®Google Scholar
• TravisRCKeyTJAllenNESerum androgens and prostate cancer among 643 cases and 643 controls in the European Prospective Investigation into Cancer and NutritionInt J Cancer20071211331133817514649
   PubMed Web of Science ®Google Scholar
• RoddamAWAllenNEApplebyPKeyTJEndogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studiesJ Natl Cancer Inst200810017018318230794
   PubMed Web of Science ®Google Scholar
• MorgentalerATestosterone replacement therapy and prostate cancerUrol Clin North Am200734555563 vii17983895
   PubMed Web of Science ®Google Scholar
• KheraMAndrogens and erectile function: a case for early androgen use in postprostatectomy hypogonadal menJ Sex Med20096Suppl. 323423819207279
   PubMed Web of Science ®Google Scholar
• CowardRMSimhanJCarsonCC3rdProstate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapyBJU Int20091031179118319154450
   PubMed Web of Science ®Google Scholar
• RhodenELMorgentalerARisks of testosterone-replacement therapy and recommendations for monitoringN Engl J Med200435048249214749457
   PubMed Web of Science ®Google Scholar
• MoralesALunenfeldBInvestigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging MaleAging Male20025748612198738
   PubMedGoogle Scholar
• SarosdyMFTestosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapyCancer200710953654117183557
   PubMed Web of Science ®Google Scholar
• MoralesABlackAMEmersonLETestosterone administration to men with testosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observationsBJU Int2009103626418671790
   PubMed Web of Science ®Google Scholar
• SamarasNFrangosEForsterALangPSamarasDAndropause: a review of the definition and treatmentEur Geriatr Med201236368373
   Web of Science ®Google Scholar
• SamarasNSamarasDLangPOChronic obstructive pulmonary disease: risk and benefit of testosterone therapyRev Med Suisse201282224222723240298
   PubMedGoogle Scholar
• DavisSRPanjariMStanczykFZClinical review: DHEA replacement for postmenopausal womenJ Clin Endocrinol Metab2011961642165321411558
   PubMed Web of Science ®Google Scholar
• PanjariMDavisSRDHEA for postmenopausal women: a review of the evidenceMaturitas20106617217920089375
   PubMed Web of Science ®Google Scholar
• LiuDDillonJSDehydroepiandrosterone stimulates nitric oxide release in vascular endothelial cells: evidence for a cell surface receptorSteroids20046927928915183694
   PubMed Web of Science ®Google Scholar
• ValentiGDentiLMaggioMEffect of DHEAS on skeletal muscle over the life span: the InCHIANTI studyJ Gerontol A Biol Sci Med Sci20045946647215123757
   PubMed Web of Science ®Google Scholar
• KostkaTArsacLMPatricotMCBerthouzeSELacourJRBonnefoyMLeg extensor power and dehydroepiandrosterone sulfate, insulin-like growth factor-I and testosterone in healthy active elderly peopleEur J Appl Physiol200082839010879447
   PubMed Web of Science ®Google Scholar
• RavagliaGFortiPMaioliFDeterminants of functional status in healthy Italian nonagenarians and centenarians: a comprehensive functional assessment by the instruments of geriatric practiceJ Am Geriatr Soc199745119612029329480
   PubMed Web of Science ®Google Scholar
• Bischoff-FerrariHAOravEJDawson-HughesBAdditive benefit of higher testosterone levels and vitamin D plus calcium supplementation in regard to fall risk reduction among older men and womenOsteoporos Int2008191307131418351428
   PubMed Web of Science ®Google Scholar
• NawataHTanakaSTakayanagiRAromatase in bone cell: association with osteoporosis in postmenopausal womenJ Steroid Biochem Mol Biol1995531651747626449
   PubMed Web of Science ®Google Scholar
• WangLWangYDWangWJZhuYLiDJDehydroepiandrosterone improves murine osteoblast growth and bone tissue morphometry via mitogen-activated protein kinase signaling pathway independent of either androgen receptor or estrogen receptorJ Mol Endocrinol20073846747917446236
   PubMed Web of Science ®Google Scholar
• ClarkeBLEbelingPRJonesJDPredictors of bone mineral density in aging healthy men varies by skeletal siteCalcif Tissue Int20027013714511907709
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorEGoodman-GruenDPatayBEndogenous sex hormones and cognitive function in older menJ Clin Endocrinol Metab1999843681368510523014
   PubMed Web of Science ®Google Scholar
• MichaelAJenawayAPaykelESHerbertJAltered salivary dehydroepiandrosterone levels in major depression in adultsBiol Psychiatry20004898999511082473
   PubMed Web of Science ®Google Scholar
• FeldmanHAJohannesCBAraujoABMohrBALongcopeCMcKinlayJBLow dehydroepiandrosterone and ischemic heart disease in middle-aged men: prospective results from the Massachusetts Male Aging StudyAm J Epidemiol2001153798911159150
   PubMed Web of Science ®Google Scholar
• YoshidaSAiharaKAzumaHDehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial functionAtherosclerosis201021231031520627295
   PubMed Web of Science ®Google Scholar
• HerringtonDMDehydroepiandrosterone and coronary atherosclerosisAnn N Y Acad Sci19957742712808597465
   PubMed Web of Science ®Google Scholar
• HerringtonDMNanjeeNAchuffSCCameronDEDobbsBBaughmanKLDehydroepiandrosterone and cardiac allograft vasculopathyJ Heart Lung Transplant19961588938820087
   PubMed Web of Science ®Google Scholar
• NakamuraSYoshimuraMNakayamaMPossible association of heart failure status with synthetic balance between aldosterone and dehydroepiandrosterone in human heartCirculation20041101787179315364798
   PubMed Web of Science ®Google Scholar
• JankowskaEABielBMajdaJAnabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survivalCirculation20061141829183717030678
   PubMed Web of Science ®Google Scholar
• ShufeltCBretskyPAlmeidaCMDHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health–National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women’s Ischemia Syndrome Evaluation (WISE)J Clin Endocrinol Metab2010954985499220739385
   PubMed Web of Science ®Google Scholar
• Barrett-ConnorEKhawKTYenSSA prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular diseaseN Engl J Med1986315151915242946952
   PubMed Web of Science ®Google Scholar
• BasarMMAydinGMertHCRelationship between serum sex steroids and Aging Male Symptoms score and International Index of Erectile FunctionUrology20056659760116140085
   PubMed Web of Science ®Google Scholar
• AlexopoulouOJamartJMaiterDErectile dysfunction and lower androgenicity in type 1 diabetic patientsDiabetes Metab20012732933611431598
   PubMed Web of Science ®Google Scholar
• FeldmanHAGoldsteinIHatzichristouDGKraneRJMcKinlayJBImpotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging StudyJ Urol199415154618254833
   PubMed Web of Science ®Google Scholar
• DavisSRDavisonSLDonathSBellRJCirculating androgen levels and self-reported sexual function in womenJAMA2005294919615998895
   PubMed Web of Science ®Google Scholar
• MoralesAJHaubrichRHHwangJYAsakuraHYenSSThe effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and womenClin Endocrinol (Oxf)1998494214329876338
   PubMed Web of Science ®Google Scholar
• VillarealDTHolloszyJOKohrtWMEffects of DHEA replacement on bone mineral density and body composition in elderly women and menClin Endocrinol (Oxf)20005356156811106916
   PubMed Web of Science ®Google Scholar
• VillarealDTHolloszyJOEffect of DHEA on abdominal fat and insulin action in elderly women and men: a randomized controlled trialJAMA20042922243224815536111
   PubMed Web of Science ®Google Scholar
• KalmanDSColkerCMSwainMATorinaGCShiQA randomized, double-blind, placebo-controlled study of 3-acetyl–7-oxo-dehydroepiandrosterone in healthy over-weight adultsCurr Ther Res200061435442
   Web of Science ®Google Scholar
• KennyAMBoxerRSKleppingerABrindisiJFeinnRBurlesonJADehydroepiandrosterone combined with exercise improves muscle strength and physical function in frail older womenJ Am Geriatr Soc2010581707171420863330
   PubMed Web of Science ®Google Scholar
• WeissEPShahKFontanaLLambertCPHolloszyJOVillarealDTDehydroepiandrosterone replacement therapy in older adults: 1- and 2-y effects on boneAm J Clin Nutr2009891459146719321570
   PubMed Web of Science ®Google Scholar
• von MuhlenDLaughlinGAKritz-SilversteinDBergstromJBettencourtREffect of dehydroepiandrosterone supplementation on bone mineral density, bone markers, and body composition in older adults: the DAWN trialOsteoporos Int20081969970718084691
   PubMed Web of Science ®Google Scholar
• JankowskiCMGozanskyWSSchwartzRSEffects of dehydroepiandrosterone replacement therapy on bone mineral density in older adults: a randomized, controlled trialJ Clin Endocrinol Metab2006912986299316735495
   PubMed Web of Science ®Google Scholar
• JankowskiCMGozanskyWSKittelsonJMVan PeltRESchwartzRSKohrtWMIncreases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogensJ Clin Endocrinol Metab2008934767477318812486
   PubMed Web of Science ®Google Scholar
• LabrieFDiamondPCusanLGomezJLBelangerACandasBEffect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal womenJ Clin Endocrinol Metab199782349835059329392
   PubMed Web of Science ®Google Scholar
• SunYMaoMSunLFengYYangJShenPTreatment of osteoporosis in men using dehydroepiandrosterone sulfateChin Med J (Engl)200211540240411940375
   PubMed Web of Science ®Google Scholar
• NairKSRizzaRAO’BrienPDHEA in elderly women and DHEA or testosterone in elderly menN Engl J Med20063551647165917050889
   PubMed Web of Science ®Google Scholar
• SchmidtPJDalyRCBlochMDehydroepiandrosterone monotherapy in midlife-onset major and minor depressionArch Gen Psychiatry20056215416215699292
   PubMed Web of Science ®Google Scholar
• WolkowitzOMReusVIKeeblerADouble-blind treatment of major depression with dehydroepiandrosteroneAm J Psychiatry199915664664910200751
   PubMed Web of Science ®Google Scholar
• WolkowitzOMReusVIRobertsEDehydroepiandrosterone (DHEA) treatment of depressionBiol Psychiatry1997413113189024954
   PubMed Web of Science ®Google Scholar
• StrousRDMaayanRLapidusRDehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophreniaArch Gen Psychiatry20036013314112578430
   PubMed Web of Science ®Google Scholar
• BlochMSchmidtPJDanaceauMAAdamsLFRubinowDRDehydroepiandrosterone treatment of midlife dysthymiaBiol Psychiatry1999451533154110376113
   PubMed Web of Science ®Google Scholar
• ReiterWJPychaASchatzlGDehydroepiandrosterone in the treatment of erectile dysfunction: a prospective, double-blind, randomized, placebo-controlled studyUrology19995359059410096389
   PubMed Web of Science ®Google Scholar
• BaulieuEEThomasGLegrainSDehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issueProc Natl Acad Sci U S A2000974279428410760294
   PubMed Web of Science ®Google Scholar
• GenazzaniARStomatiMValentinoVEffect of 1-year, low-dose DHEA therapy on climacteric symptoms and female sexualityClimacteric20111466166821942655
   PubMed Web of Science ®Google Scholar
• ArltWCalliesFvan VlijmenJCDehydroepiandrosterone replacement in women with adrenal insufficiencyN Engl J Med19993411013102010502590
   PubMed Web of Science ®Google Scholar
• MunarrizRTalakoubLFlahertyEAndrogen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire resultsJ Sex Marital Ther200228Suppl. 116517311898698
   PubMed Web of Science ®Google Scholar
• LabrieFArcherDBouchardCEffect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal womenMenopause20091692393119424093
   PubMed Web of Science ®Google Scholar
• ReiterWJSchatzlGMarkIZeinerAPychaAMarbergerMDehydroepiandrosterone in the treatment of erectile dysfunction in patients with different organic etiologiesUrol Res20012927828111585284
   PubMedGoogle Scholar
• StomatiMMonteleonePCasarosaESix-month oral dehydroepiandrosterone supplementation in early and late postmenopauseGynecol Endocrinol20001434236311109974
   PubMed Web of Science ®Google Scholar
• LabrieFArcherDBouchardCIntravaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophyMenopause20091690792219436225
   PubMed Web of Science ®Google Scholar
• LegrainSMassienCLahlouNDehydroepiandrosterone replacement administration: pharmacokinetic and pharmacodynamic studies in healthy elderly subjectsJ Clin Endocrinol Metab2000853208321710999810
   PubMed Web of Science ®Google Scholar
• TraishAMKangHPSaadFGuayATDehydroepiandrosterone (DHEA): a precursor steroid or an active hormone in human physiologyJ Sex Med201182960298222032408
   PubMed Web of Science ®Google Scholar
• SchwartzAGPashkoLLCancer prevention with dehydroepiandrosterone and non-androgenic structural analogsJ Cell Biochem Suppl1995222102178538200
   PubMedGoogle Scholar
• SchwartzAGPashkoLLDehydroepiandrosterone, glucose-6-phosphate dehydrogenase, and longevityAgeing Res Rev2004317118715177053
   PubMed Web of Science ®Google Scholar
• AllenNEApplebyPNKaaksRRinaldiSDaveyGKKeyTJLifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British womenCancer Causes Control200314657412708727
   PubMed Web of Science ®Google Scholar
• GiordanoRBonelliLMarinazzoEGhigoEArvatEGrowth hormone treatment in human ageing: benefits and risksHormones (Athens)2008713313918477550
   PubMedGoogle Scholar
• GhigoEArvatEGianottiLHuman aging and the GH-IGF-I axisJ Pediatr Endocrinol Metab19969Suppl. 32712788887170
   PubMed Web of Science ®Google Scholar
• HerschECMerriamGRGrowth hormone (GH)-releasing hormone and GH secretagogues in normal aging: Fountain of Youth or Pool of Tantalus?Clin Interv Aging2008312112918488883
   PubMed Web of Science ®Google Scholar
• BartkeACoschiganoKKopchickJGenes that prolong life: relationships of growth hormone and growth to aging and life spanJ Gerontol A Biol Sci Med Sci200156B340B34911487592
   PubMed Web of Science ®Google Scholar
• HolzenbergerMDupontJDucosBIGF-1 receptor regulates lifespan and resistance to oxidative stress in miceNature200342118218712483226
   PubMed Web of Science ®Google Scholar
• BartkeAMinireview: role of the growth hormone/insulin-like growth factor system in mammalian agingEndocrinology20051463718372315919742
   PubMed Web of Science ®Google Scholar
• Guevara-AguirreJBalasubramanianPGuevara-AguirreMGrowth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humansSci Transl Med2011370ra13
   PubMed Web of Science ®Google Scholar
• LaronZDo deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity?Mech Ageing Dev200512630530715621211
   PubMed Web of Science ®Google Scholar
• Menezes OliveiraJLMarques-SantosCBarreto-FilhoJALack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutationJ Clin Endocrinol Metab2006912093209916522693
   PubMed Web of Science ®Google Scholar
• ShechterMGinsbergSScheinowitzMFeinbergMSLaronZObese adults with primary growth hormone resistance (Laron syndrome) have normal endothelial functionGrowth Horm IGF Res20071716517017320443
   PubMed Web of Science ®Google Scholar
• ShevahOLaronZPatients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary reportGrowth Horm IGF Res200717545717166755
   PubMed Web of Science ®Google Scholar
• BessonASalemiSGallatiSReduced longevity in untreated patients with isolated growth hormone deficiencyJ Clin Endocrinol Metab2003883664366712915652
   PubMed Web of Science ®Google Scholar
• MerriamGRSchwartzRSVitielloMVGrowth hormone-releasing hormone and growth hormone secretagogues in normal agingEndocrine200322414814610297
   PubMed Web of Science ®Google Scholar
• GazzarusoCGolaMKaramouzisIGiubbiniRGiustinaACardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH: an updateJ Clin Endocrinol Metab201499182924217903
   PubMed Web of Science ®Google Scholar
• RuckerDEzzatSDiamandiAKhosraviJHanleyDAIGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling menClin Endocrinol (Oxf)20046049149915049965
   PubMed Web of Science ®Google Scholar
• GillbergPOlofssonHMallminHBlumWFLjunghallSNilssonAGBone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish menCalcif Tissue Int200270222911907704
   PubMed Web of Science ®Google Scholar
• SchneiderHJPagottoUStallaGKCentral effects of the somatotropic systemEur J Endocrinol200314937739214585082
   PubMed Web of Science ®Google Scholar
• NybergFBurmanPGrowth hormone and its receptors in the central nervous system: location and functional significanceHorm Res19964518228742113
   PubMedGoogle Scholar
• KalmijnSJanssenJAPolsHALambertsSWBretelerMMA prospective study on circulating insulin-like growth factor I (IGF-I), IGF-binding proteins, and cognitive function in the elderlyJ Clin Endocrinol Metab2000854551455511134107
   PubMed Web of Science ®Google Scholar
• RolleroAMurialdoGFonziSRelationship between cognitive function, growth hormone and insulin-like growth factor I plasma levels in aged subjectsNeuropsychobiology19983873799732206
   PubMed Web of Science ®Google Scholar
• PapadakisMAGradyDBlackDGrowth hormone replacement in healthy older men improves body composition but not functional abilityAnn Intern Med19961247087168633830
   PubMed Web of Science ®Google Scholar
• FrancoCBrandbergJLonnLAnderssonBBengtssonBAJohannssonGGrowth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a. 12-month placebo-controlled trialJ Clin Endocrinol Metab2005901466147415598680
   PubMed Web of Science ®Google Scholar
• LangeKHAndersenJLBeyerNGH administration changes myosin heavy chain isoforms in skeletal muscle but does not augment muscle strength or hypertrophy, either alone or combined with resistance exercise training in healthy elderly menJ Clin Endocrinol Metab20028751352311836279
   PubMed Web of Science ®Google Scholar
• de BoerHBlokGJVan der VeenEAClinical aspects of growth hormone deficiency in adultsEndocr Rev19951663867758433
   PubMed Web of Science ®Google Scholar
• LiuHBravataDMOlkinISystematic review: the safety and efficacy of growth hormone in the healthy elderlyAnn Intern Med200714610411517227934
   PubMed Web of Science ®Google Scholar
• CarroETrejoJLGerberATherapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosisNeurobiol Aging2006271250125716183170
   PubMed Web of Science ®Google Scholar
• VitielloMVMoeKEMerriamGRMazzoniGBuchnerDHSchwartzRSGrowth hormone releasing hormone improves the cognition of healthy older adultsNeurobiol Aging20062731832316399214
   PubMed Web of Science ®Google Scholar
• SathiavageeswaranMBurmanPLawrenceDEffects of GH on cognitive function in elderly patients with adult-onset GH deficiency: a placebo-controlled 12-month studyEur J Endocrinol200715643944717389458
   PubMed Web of Science ®Google Scholar
• BanerjeeIClaytonPEGrowth hormone treatment and cancer riskEndocrinol Metab Clin North Am20073624726317336744
   PubMed Web of Science ®Google Scholar
• BartkeAGrowth hormone and aging: a challenging controversyClin Interv Aging2008365966519281058
   PubMed Web of Science ®Google Scholar